PTJ
BIO icon

Paul Tudor Jones’s Bio-Rad Laboratories Class A BIO Stock Holding History

Paul Tudor Jones’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$299K – 2404
2021
Q3 		$299K Buy
+400
New +$300K ﹤0.01% 2039

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Paul Tudor Jones's BIO Position: Q2 2026 in Review

Paul Tudor Jones increased its Bio-Rad Laboratories Class A (BIO) stake by 384% in Q2 2026, buying an estimated $5.63M and bringing the position to 25,000 shares worth $7.34M. The position accounts for 0.01% of the portfolio, ranked #1026.

Paul Tudor Jones first reported a position in BIO in Q2 2013 and has held it in 35 quarters since. The position peaked at $10.8M in Q4 2016. 396 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Paul Tudor Jones held 25,000 shares of Bio-Rad Laboratories Class A worth $7.34M as of Q2 2026.
  • Paul Tudor Jones bought 19,839 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $5.63M.
  • Bio-Rad Laboratories Class A made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1026 holding.
  • Paul Tudor Jones first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 35 quarters since.
  • Paul Tudor Jones's Bio-Rad Laboratories Class A position peaked at $10.8M in Q4 2016.
  • 396 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.